Ultralife (ULBI) Price & Analysis

Compare

163 Followers

ULBI Stock Chart & Stats

$6.65

-$0.26(-3.42%)

At close: Jan 08 4:00 PM EST

$6.65

-$0.26(-3.42%)

Day’s Range― - ―

52-Week Range$4.07 - $9.52

Previous CloseN/A

Volume13.19K

Average Volume (3M)52.36K

Market Cap

$103.86M

Enterprise ValueN/A

Total Cash (Recent Filing)$10.94M

Total Debt (Recent Filing)$3.44M

Price to Earnings (P/E)29.6

Beta1.55

Next Earnings

Jan 29, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding16,643,614

10 Day Avg. Volume46,966

30 Day Avg. Volume52,358

Financial Highlights & Ratios

PEG Ratio-1.43

Price to Book (P/B)0.92

Price to Sales (P/S)0.75

P/FCF Ratio8.39

Enterprise Value/Market Cap0.00

Enterprise Value/Revenue0.00

Enterprise Value/Gross Profit0.00

Enterprise Value/Ebitda0.00

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Market ExpansionThe nearly complete Electrochem integration is opening new markets for ULBI, including pipeline inspection, seismic telemetry, and sonobuoys.

Regulatory ApprovalFDA approval for ULBI's partner on the medical wearable opportunity is expected to lead to significant orders.

Sales PerformanceULBI's reported sales of $50.7M exceeded estimates, showing a 32% year-over-year increase.

Bears Say

Product Specific DemandA 12.3% decrease in medical battery sales partially offset ULBI's organic growth.

Ultralife News

Ultralife Corporation Delays Q3 10-Q Filing

Ultralife ( ($ULBI) ) has released a notification of late filing. Ultralife Corporation has announced a delay in...

5d ago

ULBI

ULBI Earnings Report this Week: Is It a Buy, Ahead of Earnings?

Ultralife (ULBI) is scheduled to report 3rd quarter earnings on 10/23/2025. Regarding Q3 estimates, Wall Street analysts expect...

22d ago

ULBI

Ultralife receives $5.2M award from U.S. DLA for BA-5390 batteries

Ultralife (ULBI) has received an award valued at approximately $5.2M from the U.S. Government’s Defense Logistics Agency for...

2M ago

ULBI

Ultralife’s Earnings Call: Growth Amid Challenges

Ultralife (($ULBI)) has held its Q2 earnings call. Read on for the main highlights of the call. Ultralife...

3M ago

ULBI

Ultralife Corporation Reports Mixed Q2 2025 Results

Ultralife ( ($ULBI) ) has released its Q2 earnings. Here is a breakdown of the information Ultralife presented...

3M ago

ULBI

Ultralife reports Q2 adjusted EPS 7c vs 22c last year

Reports Q2 revenue $48.6M vs $42.983M last year. “The second quarter was a challenging period for Ultralife (ULBI)....

3M ago

ULBI

Ultralife Holds Annual Stockholders Meeting, Elects Directors

Ultralife ( ($ULBI) ) has provided an announcement. On July 16, 2025, Ultralife Corporation held its Annual Meeting...

4M ago

ULBI

Two new option listings and nine option delistings on June 23rd

New option listings for June 23rd include CAI International Inc (CAI) and Global X Msci Colombia Etf (COLO)....

5M ago

AHT

CAI

Ultralife’s Promising Growth: Buy Rating Backed by Strategic Acquisitions and Market Expansion

Analyst Josh Sullivan of Benchmark Co. reiterated a Buy rating on Ultralife (ULBI – Research Report), retaining the...

6M ago

ULBI

Ultralife’s Promising Growth: Strategic Acquisitions, Innovative Products, and Strong Financial Performance Drive Buy Rating

Benchmark Co. analyst Josh Sullivan reiterated a Buy rating on Ultralife (ULBI – Research Report) yesterday and set...

6M ago

ULBI

Ultralife Corporation Reports Strong Q1 Revenue Growth

Ultralife ( ($ULBI) ) has released its Q1 earnings. Here is a breakdown of the information Ultralife presented...

6M ago

ULBI

Ultralife’s Earnings Call: Growth Amid Challenges

Ultralife (($ULBI)) has held its Q1 earnings call. Read on for the main highlights of the call. Ultralife...

6M ago

ULBI

Ultralife reports Q1 adjusted EPS 13c vs 21c last year

Reports Q1 revenue $50.746M vs $41.927M last year. “We delivered a strong first quarter with a 21% revenue...

6M ago

ULBI

Ultralife’s Earnings Call: Mixed Results and Strategic Moves

Ultralife (($ULBI)) has held its Q4 earnings call. Read on for the main highlights of the call. Ultralife’s...

7M ago

ULBI

ULBI FAQ

What was Ultralife’s price range in the past 12 months?

Ultralife lowest stock price was $4.07 and its highest was $9.52 in the past 12 months.

What is Ultralife’s market cap?

Ultralife’s market cap is $103.86M.

When is Ultralife’s upcoming earnings report date?

Ultralife’s upcoming earnings report date is Jan 29, 2026 which is in 78 days.

How were Ultralife’s earnings last quarter?

Currently, no data Available

Is Ultralife overvalued?

According to Wall Street analysts Ultralife’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Ultralife pay dividends?

Ultralife does not currently pay dividends.

What is Ultralife’s EPS estimate?

Ultralife’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Ultralife have?

Ultralife has 16,643,614 shares outstanding.

What happened to Ultralife’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Ultralife?

Currently, no hedge funds are holding shares in ULBI

Ultralife Stock Smart Score

Neutral

Fundamentals

Return on Equity

2.35%

Trailing 12-Months

Asset Growth

30.12%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Ultralife

Ultralife Corporation (ULBI) is a global leader in the design and manufacture of advanced battery and energy solutions. The company operates primarily in two segments: the Battery and Energy Products segment, which focuses on lithium batteries for various applications, including medical devices, military, and consumer electronics; and the Communications segment, which provides critical communication systems and solutions for the defense and commercial sectors. Ultralife's core products include rechargeable batteries, power systems, and specialty communications equipment, making it a key player in the energy and power solutions market.

Ultralife (ULBI) Earnings & Revenues

Historic Earnings Reports

ULBI Earnings Call

Q2 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call presented a mixed picture with significant revenue growth driven by government defense sales and successful integration of Electrochem, while challenges included a decline in operating income, gross margins, and sales in key segments. The company showed progress in new product development and debt reduction, but faced headwinds from tariffs and increased operating expenses.View all ULBI earnings summaries